In today’s court ruling in Association for Molecular Pathology, et al. v. USPTO, et al., Judge Robert Sweet rejected claims by Myriad that invaliding the patents would be an unconstitutional taking, or violate the WTO TRIPS Agreement. In discussing the TRIPS, Judge Sweet mentioned Article 8.1 and 27.3 of the TRIPS.
Ben King of the New Zealand Ministry of Foreign Affairs and Trade has kindly provided some details of the April 13, 2010 meeting between ACTA negotiators and private sector stakeholders. The event is “by invitation only” but we are told it will include civil society groups. Inquiries about April 13 event can be forwarded to trademarks@med.govt.nz
——– Forwarded Message ——–
From: KING, Ben (WSH)
To: Jamie Love
Subject: From New Zealand Embassy
Date: 03/28/2010[UNCLASSIFIED]
Hi Jamie
KEI on leaked EU Canada trade agreement IPR Chapter
Michael Geist has leaked the lasted draft of the intellectual property chapter of the Canada – EU Comprehensive Economic Trade Agreement. These are some brief comments on the new document.
It applies to both parties.
When a very large trading partner negotiates with a smaller one, it is sometimes overlooked that the norms are designed to bind both parties. So the Canada/EU IPR agreement should be of interest to Canada and the 27 members of the European Union.NAFTA provisions on enforcement of intellectual property rights
In looking at how enforcement norms are being changed in ACTA, it is helpful to review the enforcement chapter of NAFTA.
Article 1714: Enforcement of Intellectual Property Rights: General Provisions
USTR asks that briefing on position on ACTA transparency be off the record
The January 2010 Guadalajara, Mexico, meeting on ACTA included an agenda item on transparency. I asked USTR if they could provide TACD with a briefing on transparency and other issues in the negotiation. The one hour briefing was held today. I can report nothing of what the USTR said at the meeting, other than they insisted it be off the record. TACD has asked for an on the record meeting, but that apparently will have to wait until after the New Zealand meetings are held the week of April 12. Continue Reading
The Carbon Dioxide Capture Technology Prize
Senators Barrasso, Bingam and Enzi have proposed a prize fund for “competitive technology financial awards for carbon dioxide capture from media in which the concentration of carbon dioxide is dilute.” This bill is is now being proposed as an amendment to an energy bill that might see some action this year. A few things to highlight.
- First, the prize requires that:
“an applicant shall agree to vest the intellectual property of the applicant derived from the technology in 1 or more entities that are incorporated in the United States.”
The ACTA text, as a Wordle picture
1 Entertainment Industy letter to Obama on ACTA
Just in case anyone does not appreciate how difficult it will be to change the USTR direction on ACTA, note that today the USTR proudly put this letter on the USTR Blog:
http://www.ustr.gov/about-us/press-office/blog/2010/march/new-information-ustrgov/acta
(Maybe best to first skip down to see who signed it).
March 22, 2010
The Honorable Barack Obama
President of the United States
The White House
1600 Pennsylvania Avenue, NW
Washington, D.C. 205005 Why would blind people get less than the Olympic Committee? Choosing between Convention, Recommendation and Declaration
When I first heard David Mann representing the World Blind Union at the information session of November 2003 SCCR, call for the “creation of international agreements which would allow the unhindered transfer of accessible material created in one country to blind and partially sighted people in another country”, I did not know that this issue had been the subject of a WIPO/UNESCO report in 1983, which had then proposed Model Provisions Concer Continue Reading
Tie up with Pfizer in India a mistake, says USPTO
On March 5, 2010, KEI published documents received from a FOIA request, about a collaboration between the USPTO and Pfizer to hold workshops in India. On March 11, the USPTO responded with a statement of regret concerning the collaboration, which it termed a mistake.
The Business Standard of India has written an article about the USPTO/Pfizer collaboration here:
